• 1
    Byar DP. The Veteran Administration Cooperative Urological Research Group's Studies of cancer of the prostate. Cancer 1973; 32: 112630
  • 2
    Leuprolide Study Group. Leuprolide versus diethylstilboestrol for metastatic prostate cancer. N Engl J Med 1984; 311: 12816
  • 3
    Chang A, Yeap B, Davis T et al. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilboestrol. J Clin Oncol 1996; 14: 22507
  • 4
    Dearnaley D, Capp A, Gadd J, Huddart R. Stilboestrol in the management of refractory prostate cancer. Br J Cancer 1997; 76: 22
  • 5
    Shearer R, Hendry W, Somerville IF, Fergusson J. Plasma testosterone: an accurate monitor of hormone treatment in prostate cancer. Br J Urol 1973; 45: 66877
  • 6
    Robinson MRG. A further analysis of European Organisation for Research and Treatment of Cancer protocol 30805. Cancer 1993; 72: 38557
  • 7
    Bishop MC. Experience with low-dose oestrogen in the treatment of advanced prostate cancer: a personal view. Br J Urol 1996; 78: 9218
  • 8
    Harland S, Mufti G, Gelister J, Anjum I, Nicholson P. Hydrocortisone and stilboestrol in combination for castration relapsed prostate cancer. Proc Am Soc Clin Oncol 1998; 17: 1251
  • 9
    Plowman P, Perry L, Chard T. Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostate cancer. Br J Urol 1987; 59: 2557
  • 10
    Dowsett M, Shearer R, Ponder B, Malone P, Jeffcoate S. The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients. Br J Cancer 1988; 57: 1902
  • 11
    Huggins C & Hodges C. Studies on prostate cancer: effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 2937
  • 12
    Farnsworth W. A direct effect of estrogens on prostatic metabolism of testosterone. Invest Urol 1969; 6: 4237
  • 13
    Belitsky P, Elhilali M, Oliver J. Effect of stilbestrol on the isoenzymes of lactate dehydrogenase in benign and malignant prostatic tissue. J Urol 1969; 104: 4536
  • 14
    Castagnetta L & Carruba G. Human prostate cancer: a direct role for oestrogens. Ciba Foundation Symposium 1995; 191: 2869
  • 15
    Carruba G, Miceli D, D'Amico D et al. Sex-steroid upregulate e-cadherin expression in hormone responsive LNCaP human prostate cancer cells. Biochem Biophys Res Commun 1995; 212: 62431
  • 16
    Alfthan O & Holsti L. Prevention of gynaecomastia by local roentgen irradiation in estrogen-treated prostatic carcinoma. Scand J Urol Nephrol 1969; 3: 1837
  • 17
    Gleave M, Goldenberg SL, Bruchovsky N, Rennie P. Intermittent androgen suppression for prostate cancer. Rationale and clinical experience. Prostate Cancer Prostatic Dis 1998; 1: 28996